Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Stent-valves for valve replacement and associated methods and systems for surgery

a valve replacement and valve valve technology, applied in the field of stent valves, can solve the problems of increasing the risks, death, and limits of patients' activities, and achieve the effect of facilitating a surgical approach and reducing risks

Inactive Publication Date: 2007-09-13
SYMETIS
View PDF19 Cites 1159 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

The present invention provides systems, methods, and devices for replacing damaged cardiac valves with stent-valves. The invention offers a minimally-invasive surgical approach that reduces risks associated with traditional surgeries and secondary surgeries. The stent-valves include a valve component and at least one stent component, which can be expanded within the patient's body while remaining attached to a delivery device. The stent-valves can be secured axially to the valve in need of replacement using sutures, hook-and-loop fastening systems, or other means. The stent-valves may include a lattice structure with cells that provide added support and facilitate recapture of the stent-valve from the partially-expanded configuration to the collapsed configuration. Overall, the invention offers a safer and more effective method for replacing damaged cardiac valves.

Problems solved by technology

However, tissue adherences resulting from the first surgery may increase the risks (e.g., death) associated with subsequent valve replacement surgeries.
Such anti-coagulant treatment significantly limits patients' activities and can cause various other complications.
Biological valves do not require such anti-coagulation treatment but typically fail within 10-15 years.
These PHVT attempts have various shortcomings, including their inability to ensure proper positioning and stability of the replacement valve within the patient's body.
Conventional closure devices for closing access orifices are also lacking in several respects, including the looseness of their fit which can cause bleeding after surgery.
These closure devices also lack a central lumen, which renders them incompatible with guide wire delivery systems.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Stent-valves for valve replacement and associated methods and systems for surgery
  • Stent-valves for valve replacement and associated methods and systems for surgery
  • Stent-valves for valve replacement and associated methods and systems for surgery

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0061]FIGS. 1A-3B show components 100, 200, and 300 for use in replacing, for example, a failed (e.g., degenerated) aortic valve, mitral valve, or pulmonary cardiac valve (e.g., in a pediatric patient) in accordance with some embodiments of the present invention. More particularly, FIGS. 1A and 1B show a valve component 100. FIGS. 2A-2C show a stent component 200 for housing valve component 100. FIGS. 3A and 3B show a stent component 300 for housing stent component 200 and valve component 100. A device that includes components 100 and 200 may be referred to as a single-stent-valve. A device that additionally includes component 300 may be referred to as a double-stent-valve.

[0062]FIG. 4 shows a double-stent-valve 400 that includes valve component 100, stent component 200, and stent component 300 in accordance with some embodiments of the present invention. Double-stent-valve 400 may replace a failed native or artificial valve. As used herein, a “native valve” refers to a valve natur...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

Stent-valves (e.g., single-stent-valves and double-stent-valves), associated methods and systems for their delivery via minimally-invasive surgery, and guide-wire compatible closure devices for sealing access orifices are provided.

Description

CROSS-REFERENCE TO RELATED APPLICATIONS [0001] The present application claims the benefit of U.S. Provisional Patent Application Nos. 60 / 753,071, filed Dec. 22, 2005, 60 / 755,590, filed Dec. 29, 2005, and 60 / 843,181, filed Sep. 7, 2006, each of which is incorporated by reference herein in its entirety.FIELD OF THE INVENTION [0002] Embodiments of the present invention relate to stent-valves, associated methods and systems for their delivery via minimally-invasive surgery, and guide-wire compatible closure devices for sealing access orifices. BACKGROUND OF THE INVENTION [0003] Conventional approaches for cardiac valve replacement require the cutting of a relatively large opening in the patient's sternum (“sternotomy”) or thoracic cavity (“thoracotomy”) in order to allow the surgeon to access the patient's heart. Additionally, these approaches require arrest of the patient's heart and a cardiopulmonary bypass (i.e., use of a heart-lung bypass machine to oxygenate and circulate the patie...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): A61F2/24
CPCA61F2/2418A61F2/243A61F2/2433A61F2/2436A61F2/2472A61F2230/0078A61F2220/0016A61F2220/0075A61F2220/0083A61F2230/0013A61F2230/0067A61F2250/006A61F2/90A61F2/966A61F2002/9511A61F2210/0042A61F2250/001A61F2250/0039A61F2002/9505A61F2002/9665A61F2210/0014A61F2/9522A61B17/12031A61B17/12131A61B2017/00606A61B2017/00623A61B2017/12095A61B17/0057A61M39/22A61F2/82A61F2/2427A61F2002/9534A61F2220/0033A61F2230/001
Inventor VON SEGESSER, LUDWIG K.DELALOYE, STEPHANE
Owner SYMETIS
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com